Investor / Analysts call recording for the Quarter- 4 and Financial year ending March 31, 2026.
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Orchid Pharma Limited has submitted a regulatory filing informing stakeholders that the audio recording of its Q4 FY2026 Earnings Call held on May 26, 2026 at 04:30 PM IST is now available on the company's website. The filing, made under SEBI Regulation 30, confirms this was an audio conference call with no video recording. This is a standard procedural disclosure in compliance with SEBI listing requirements. The actual content of the earnings call discussion is contained in the audio file rather than in this text filing.
This is a procedural filing that merely provides access to the earnings call recording. The filing itself does not contain any new financial details, guidance, or strategic updates for investors to react to.